We have reached the final day of IAS 2025 the, 13th IAS Conference on HIV Science! A day full of the latest science leads up to the rapporteur report-back and closing sessions.
Coming up today
Convert to your time zone through the IAS 2025 programme.
09:00 CAT
The final plenary, “Getting to grips with prevention”, focuses on HIV vaccine discovery medicine, why we have not reached triple elimination, and evidence-based innovations to simplify and de-medicalize PrEP choice. It closes with the awarding of the JIAS Impact Awards.
10:45 CAT
The symposium, “State of the ART”, reviews where we are with HIV treatment, emerging drug resistance and ART drug interactions. “From insight to impact: Advances in understanding and achieving HIV immunological control” showcases the latest on immunological control of HIV, biomarkers of post-treatment HIV immunological control, bNAbs, NK cells and CAR-T cell therapy for HIV remission.
An oral abstract session on mpox includes an epidemiological profile of early cases of mpox and the syndemic interplay between HIV and mpox among refugees in Uganda. Sessions also offer: new insights on lenacapavir for HIV prevention, reflecting on the PURPOSE trials; findings on HIV, climate change and mobility; and a focus on community-led monitoring strengthening the HIV response.
12:45 CAT
The symposium, “Disrupting stigma”, looks at drivers and measurement of this abiding barrier to accessing services.
You can choose from no less than five oral abstract sessions at this time. “Basic science highlights: Cutting-edge research and implications” includes findings from Uganda on the impact of BCG vaccination on innate immune responses in HIV-exposed infants. “HIV treatment and prevention in pregnancy” includes sharing data from the Antiretroviral Pregnancy Registry on pregnancy and neonatal outcomes following prenatal exposure to cabotegravir.
“Big money and the big picture: Funding and HIV epidemiology” includes the projected impact of HIV budget cuts across 26 countries. “I will not lower my voice”: Experiences from trans and gender-diverse communities” brings us insights from a number of countries across the globe, including findings from Vietnam on stigma leading to substance use. And “Revolutionizing HIV: AI, equity and the next frontier” looks at blockchain solutions for client data integrity and pharmaceutical supply chain resilience, using mobile chest X-rays and AI to improve TB diagnosis among people living with HIV in Nigeria, and more.
13:45 CAT
Oral abstract sessions focus on the latest in tuberculosis treatment and using technology for health applications, with an abstract on the MARVIN chatbot, an AI-powered preventive intervention for stigma and suicidal ideation in HIV self-management.
The final symposium sessions of IAS 2025 take place:
- “Pregnancy and long-acting ARVs for prevention and treatment” presents new data on lenacapavir and cabotegravir in pregnancy and breastfeeding, outlines plans for inclusive research, and discusses priority actions.
- “Rethinking approaches to clinical studies” focuses on designs to optimize impact, including Learn-As-you-GO designs, and placing implementation science, social behavioural science and community inclusion at the centre of clinical trials.
- “Are integration and equity at odds?” addresses the context of less funding being available for HIV and the move towards integration as the focus shifts to entire health systems instead of siloed or disease-specific responses.
- “From lived expertise to action” celebrates the expertise that communities and key populations bring to the HIV response.
15:15 CAT
In the rapporteur report-back and closing session, lead rapporteurs across all conference tracks synthesize key presentations and insights from the week (you can find all rapporteur reports here), followed by a summary from IAS Executive Director Birgit Poniatowski. The session features remarks by IAS 2025 Local Chair Jeanine Condo and a community address by South Africa’s HER Voice Fund Ambassador Nomonde Ngema. International Chair and IAS President Beatriz Grinsztejn delivers concluding remarks.
Reminder of bag policy
If you are travelling after IAS 2025 ends today, please remember that only small handbags and laptop bags are allowed inside the venue. Storage space is limited, so please leave larger bags and suitcases at your hotel.
The IAS 2025 exhibition
The exhibition is open from 10:30 to 15:00 CAT today. Explore cutting-edge products and services and chat with representatives of key organizations in the HIV response.
The poster exhibition
You can interact with authors at their posters from 12:15 to 13:15. Some to look out for today:
- A look at mpox prevalence among men who have sex with men in Kenya
- An exploration of breaking the chain of TB transmission through efficient programme implementation
JIAS
The Journal of the International AIDS Society supplement, “Expanding access to a choice-based HIV prevention market”, has just been launched. These articles from diverse contexts illustrate lessons learnt and challenges associated with expanding access to HIV prevention options across varied contexts and populations.
Find all the oral abstracts from IAS 2025 in the Journal of the International AIDS Society abstract supplement.
Official media partners
Thanks to our major industry sponsors
Join the conversation
Connect online by following us and help spread the word by sharing suggested social posts and graphics from our IAS 2025 social toolkit.
